Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study

Current prescribing practices for major depressive disorder (MDD) produce limited treatment success. Although pharmacogenomics may improve outcomes by identifying genetically inappropriate medications, studies to date were limited in scope. Outpatients (N = 1167) diagnosed with MDD and with a patien...

Celý popis

Podrobná bibliografia

Vydané v:	Journal of psychiatric research Ročník 111; s. 59 - 67
Hlavní autori:	Greden, John F., Parikh, Sagar V., Rothschild, Anthony J., Thase, Michael E., Dunlop, Boadie W., DeBattista, Charles, Conway, Charles R., Forester, Brent P., Mondimore, Francis M., Shelton, Richard C., Macaluso, Matthew, Li, James, Brown, Krystal, Gilbert, Alexa, Burns, Lindsey, Jablonski, Michael R., Dechairo, Bryan
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England Elsevier Ltd 01.04.2019
ISSN:	0022-3956, 1879-1379, 1879-1379
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!